Actos® Bladder Cancer Settlement Moves Forward

by Staff Blogger | October 9th, 2015

In May, Takeda Pharmaceuticals, Inc., the maker of Actos®, offered to settle thousands of bladder cancer lawsuits for $2.4 billion. Here’s a link to a previous post we made in May about the settlement.

When the offer was made earlier this year, victims still needed to agree to the terms of the settlement before it could be finalized. Now, a majority of plaintiffs have signed on to participate in the settlement.

Last month, Takeda issued a press release that states 96 percent of claimants agreed to the terms of the settlement. Once it’s determined that 97 percent of those individuals meet the criteria to participate, the deal will move one step closer to becoming final.

Once the settlement is official, the company says they will have laid seven of the nine Actos bladder cancer lawsuits they are facing to rest.

Takeda states the settlement will have no effect on the company’s support and distribution of Actos.

At Ponce Law, our Nashville Actos bladder cancer lawyers recognize the struggles many individuals have faced in the wake of using the drug to battle another serious disease. That’s why we’re hopeful this settlement can bring peace and closure to those who were harmed by the drug.